Please assess the completion status of the following clinical trial:

Trial Title: Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Confirmed active head lice infestation~* Parent or guardian must be able to apply treatment~Exclusion Criteria:~* Allergy to pediculicides or hair care products~* Scalp conditions other than head lice~* Previous head lice treatment within the past 4 weeks~* Current antibiotic treatment

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 24 Months
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): MALG

Based on this trial design, predict the completion outcome and termination type (if applicable).